Status:

COMPLETED

Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis

Lead Sponsor:

Center for Medicinal Cannabis Research

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study is to determine whether or not smoked marijuana improves spasticity in patients with multiple sclerosis.

Detailed Description

Studies of cannabinoids for spasticity in MS have had mixed results but clinical studies have been small, generally not properly controlled, with results controversial, and difficult to interpret. Rec...

Eligibility Criteria

Inclusion

  • Clinically definite or probable, laboratory-supported MS
  • Complaints of spasticity and at least moderate increase in tone as evidenced by a score of \>= 2 on the Modified Ashworth Scale at either the elbow, hip, or knee
  • If on disease-modifying therapy ("ABC"), have been on a stable dose for at least six months
  • Fluent in English
  • If not cannabis-naive, must refrain from smoking cannabis for two weeks prior to screening (confirmed by urinalysis)
  • If on either lioresal (Baclofen) or tizanadine (Zanaflex), have been on a stable dose for at least three months
  • \>=18 years of age

Exclusion

  • Axis I psychiatric disorder especially depression or significant neurological disease other than MS as determined by the PI
  • Recent history of active substance abuse defined as daily use for at least 14 days within the past month
  • Drug use restrictions, eg, subjects on probation or parole, employment involving high risk to themselves and/or the public (airline pilot, bus driver, etc.)
  • Any unstable medical health problem
  • Any known pulmonary disorders, including tuberculosis, asthma, or COPD
  • Pregnant or nursing
  • Require benzodiazepines to control spasticity
  • Require high doses of analgesic medications on a daily basis

Key Trial Info

Start Date :

September 1 2001

Trial Type :

INTERVENTIONAL

End Date :

March 1 2005

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00248378

Start Date

September 1 2001

End Date

March 1 2005

Last Update

June 23 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UC San Diego Medical Center

San Diego, California, United States, 92093